JNJ

189.88

-0.38%↓

ABT

125.64

-0.89%↓

MDT

93.37

-0.43%↓

VEEV

293.8

+0.2%↑

A

147.26

-0.64%↓

JNJ

189.88

-0.38%↓

ABT

125.64

-0.89%↓

MDT

93.37

-0.43%↓

VEEV

293.8

+0.2%↑

A

147.26

-0.64%↓

JNJ

189.88

-0.38%↓

ABT

125.64

-0.89%↓

MDT

93.37

-0.43%↓

VEEV

293.8

+0.2%↑

A

147.26

-0.64%↓

JNJ

189.88

-0.38%↓

ABT

125.64

-0.89%↓

MDT

93.37

-0.43%↓

VEEV

293.8

+0.2%↑

A

147.26

-0.64%↓

JNJ

189.88

-0.38%↓

ABT

125.64

-0.89%↓

MDT

93.37

-0.43%↓

VEEV

293.8

+0.2%↑

A

147.26

-0.64%↓

Search

Repligen Corp

Закрыт

СекторЗдравоохранение

166.55 0.96

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

165.68

Макс.

167.39

Ключевые показатели

By Trading Economics

Доход

9M

15M

Продажи

13M

182M

Рентабельность продаж

8.152

Сотрудники

1,778

EBITDA

7.7M

44M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+8.07% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

28 окт. 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

2B

8.7B

Предыдущая цена открытия

165.59

Предыдущая цена закрытия

166.55

Новостные настроения

By Acuity

50%

50%

148 / 373 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Strong Bearish Evidence

Repligen Corp График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

26 окт. 2025 г., 23:52 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

26 окт. 2025 г., 23:52 UTC

Обсуждения рынка

Nikkei May Rise on Weaker Yen -- Market Talk

26 окт. 2025 г., 23:46 UTC

Обсуждения рынка

Oil Rises Amid Ongoing Supply Concerns -- Market Talk

26 окт. 2025 г., 23:41 UTC

Обсуждения рынка

Gold Falls; U.S.-China Trade Deal Optimism Overcomes Signs of Cooler U.S. Inflation -- Market Talk

26 окт. 2025 г., 23:34 UTC

Отчет

Sinopharm Group 9-Mos Oper Pft CNY10.87B Vs. Pft CNY10.84B >1099.HK

26 окт. 2025 г., 23:32 UTC

Отчет

Sinopharm Group 9-Mos Net CNY5.31B Vs. Net CNY5.28B >1099.HK

26 окт. 2025 г., 23:30 UTC

Отчет

Sinopharm Group 9-Mos Rev CNY431.48B Vs. CNY442.42B >1099.HK

26 окт. 2025 г., 22:29 UTC

Отчет

WuXi AppTec 3Q Rev CNY12.06B ; up 15.3% on Year>603259.SH

26 окт. 2025 г., 22:29 UTC

Отчет

WuXi AppTec: Higher Contributions From Contract Research Development and Manufacturing Organization Unit Supported Results>603259.SH

26 окт. 2025 г., 22:29 UTC

Отчет

WuXi AppTec: Results Also Boosted From Divestment Gains >603259.SH

26 окт. 2025 г., 22:29 UTC

Отчет

WuXi AppTec 3Q Net CNY5.13B ; up 82.9% on Year>603259.SH

26 окт. 2025 г., 22:16 UTC

Отчет

Stock Futures Rise Ahead of Mag 7 Earnings, Fed Decision -- Barrons.com

26 окт. 2025 г., 21:33 UTC

Приобретения, слияния, поглощения

Novartis Agrees to Acquire Avidity Biosciences for $12 Billion -- WSJ

26 окт. 2025 г., 19:29 UTC

Приобретения, слияния, поглощения

Novartis Deal Values Avidity Biosciences At $12 Billion -- Barrons.com

26 окт. 2025 г., 06:39 UTC

Отчет

CITIC Securities 3Q Rev CNY22.78B Vs. CNY15.96B >6030.HK

26 окт. 2025 г., 06:39 UTC

Отчет

CITIC Securities: Higher Income From Brokerage, Investment Banking Supported Results>6030.HK

26 окт. 2025 г., 06:39 UTC

Отчет

CITIC Securities 3Q Net CNY9.44B Vs. Net CNY6.23B >6030.HK

24 окт. 2025 г., 21:24 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

24 окт. 2025 г., 21:24 UTC

Обсуждения рынка

Moody's Sees France With Increased Risk of Political Dysfunction -- Market Talk

24 окт. 2025 г., 21:07 UTC

Отчет

The Score: Netflix, Amazon.com, Six Flags and More Stocks That Defined the Week -- WSJ

24 окт. 2025 г., 20:58 UTC

Отчет

S&P 500 Climbs to New Record on Strong Earnings -- WSJ

24 окт. 2025 г., 20:50 UTC

Обсуждения рынка

Financial Services Roundup: Market Talk

24 окт. 2025 г., 20:40 UTC

Отчет

Intel Expects Chip Shortages on Better PC Demand. Here's Why AMD Is Winning Too. -- Barrons.com

24 окт. 2025 г., 20:24 UTC

Отчет

General Dyamics Stock Rises on Earnings. Aerospace Was a Standout. -- Barrons.com

24 окт. 2025 г., 20:23 UTC

Отчет

General Dyamics Stock Rises on Earnings. Aerospace Was a Standout. -- Barrons.com

24 окт. 2025 г., 20:13 UTC

Отчет

These Stocks Moved the Most Today: Intel, AMD, Ford, Deckers, Newmont, Nextracker, Booz Allen, Coinbase, and More -- Barrons.com

24 окт. 2025 г., 20:07 UTC

Обсуждения рынка

Different-Cell Imputation Rose Proportionally in September CPI -- Market Talk

24 окт. 2025 г., 19:40 UTC

Обсуждения рынка

Treasury Yields Mixed, Dollar Stronger Ahead of Fed Week -- Market Talk

24 окт. 2025 г., 19:35 UTC

Обсуждения рынка

Oil Rally on U.S. Russia Sanctions Loses Steam -- Market Talk

24 окт. 2025 г., 19:33 UTC

Отчет

IBM and Google Are Also Making Moves in Quantum. Don't Count Out the Bigger Players. -- Barrons.com

Сравнение c конкурентами

Изменение цены

Repligen Corp Прогноз

Целевая цена

By TipRanks

8.07% рост

Прогноз на 12 месяцев

Средняя 179.75 USD  8.07%

Максимум 220 USD

Минимум 135 USD

Основано на мнении 15 аналитиков Wall Street, спрогнозировавших целевые цены для Repligen Corp на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

15 ratings

12

Покупка

3

Удержание

0

Продажа

Техническая оценка

By Trading Central

125.31 / 140.7Поддержка и Сопротивление

Краткосрочная

Strong Bearish Evidence

Среднесрочная

Strong Bearish Evidence

Долгосрочная

Strong Bearish Evidence

Настроения

By Acuity

148 / 373Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
help-icon Live chat